These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15757489)

  • 1. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.
    Nakamura A; Akiyama K; Takai T
    Expert Opin Ther Targets; 2005 Feb; 9(1):169-90. PubMed ID: 15757489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.
    Nakamura A; Kubo T; Takai T
    Adv Exp Med Biol; 2008; 640():220-33. PubMed ID: 19065795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer.
    Takai T; Nakamura A; Akiyama K
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Sep; 3(3):187-97. PubMed ID: 12871025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of immunoglobulin receptors and the effects on clinical outcome in cancer immunotherapy and other immune diseases: a general review.
    Kaifu T; Nakamura A
    Int Immunol; 2017 Jul; 29(7):319-325. PubMed ID: 28910969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.
    Hogarth PM; Pietersz GA
    Nat Rev Drug Discov; 2012 Mar; 11(4):311-31. PubMed ID: 22460124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc receptors and their interaction with complement in autoimmunity.
    Schmidt RE; Gessner JE
    Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis.
    Wu Y; Pan W; Hu X; Zhang A; Wei W
    Biochem Pharmacol; 2021 Jan; 183():114360. PubMed ID: 33301760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Fc receptor in autoimmune disease.
    Li X; Kimberly RP
    Expert Opin Ther Targets; 2014 Mar; 18(3):335-50. PubMed ID: 24521454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches.
    Nimmerjahn F
    J Clin Immunol; 2016 May; 36 Suppl 1():83-7. PubMed ID: 26957094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
    Ben Mkaddem S; Benhamou M; Monteiro RC
    Front Immunol; 2019; 10():811. PubMed ID: 31057544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitors.
    Sondermann P; Oosthuizen V
    Immunol Lett; 2002 Jun; 82(1-2):51-6. PubMed ID: 12008034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptors and their role in immune regulation and autoimmunity.
    Takai T
    J Clin Immunol; 2005 Jan; 25(1):1-18. PubMed ID: 15742153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of Fcgamma receptors in immune regulation and diseases].
    Takai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):318-26. PubMed ID: 16276045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of Fc receptors on the development of autoimmune diseases.
    Kleinau S
    Curr Pharm Des; 2003; 9(23):1861-70. PubMed ID: 12871190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin-A in the regulation of immunity in health and disease.
    Morianos I; Papadopoulou G; Semitekolou M; Xanthou G
    J Autoimmun; 2019 Nov; 104():102314. PubMed ID: 31416681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling by Antibodies: Recent Progress.
    Bournazos S; Wang TT; Dahan R; Maamary J; Ravetch JV
    Annu Rev Immunol; 2017 Apr; 35():285-311. PubMed ID: 28446061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc receptors as determinants of allergic reactions.
    Kraft S; Novak N
    Trends Immunol; 2006 Feb; 27(2):88-95. PubMed ID: 16324885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating and inhibitory FcgammaRs in autoimmune disorders.
    Nimmerjahn F
    Springer Semin Immunopathol; 2006 Dec; 28(4):305-19. PubMed ID: 17115158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory ITAMs as novel regulators of immunity.
    Blank U; Launay P; Benhamou M; Monteiro RC
    Immunol Rev; 2009 Nov; 232(1):59-71. PubMed ID: 19909356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM21 and the Function of Antibodies inside Cells.
    Rhodes DA; Isenberg DA
    Trends Immunol; 2017 Dec; 38(12):916-926. PubMed ID: 28807517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.